Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Karen-Sue B. Carlson MD, PhD
Associate Professor
Department of Medicine
Division of Hematology and Oncology - Medicine

OFFICE ADDRESS:
Clinical Cancer Center
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
09/1991 - 05/1995 B.A., B.A. Southern Methodist University, Dallas, TX
06/1996 - 05/2004 M.D., Ph. D., University of Wisconsin, Madison, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/2004 - 06/2006 Postdoctoral Fellow, Neurobiology and Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065
07/2006 - 06/2008 Intern and Resident (Medical Research Track), Internal Medicine, Weill Cornell College of Medicine, 1300 York Avenue, New York, NY 10065
07/2008 - 06/2011 Clinical Fellowship, Internal Medicine, Hematology and Oncology, Weill Cornell College of Medicine, 1230 York Avenue, New York, NY 10065
09/2013 - 12/2014 CTSI Methods in Grant Preparation CourseCollege of Wisconsin, Medical College of Wisconsin, Milwaukee, WI
01/2016 - 04/2016 Responsible Conduct of Research, Medical College of Wisconsin, Milwaukee, WI
07/07/2016 - 07/09/2016 The Genome Access Course, Cold Spring Harbor Laboratories, Cold Spring Harbor, NY
07/2018 - 05/2019 Kern Kinetic3 Teaching Academy, Medical College of Wisconsin, Milwaukee, WI
07/06/2019 - 07/11/2019 Applied Bioinformatics Course, Mount Desert Island Biological Laboratories, Bar Harbor, ME

FACULTY APPOINTMENTS:
06/2006 - 12/2012 Adjunct Faculty, The Rockefeller University, New York, NY
07/2011 - 12/2012 Assistant Professor, Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medical Center; New York Presbyterian Hospital, New York, NY
03/01/2013 - 06/30/2020 Assistant Professor, Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
03/01/2013 - 12/31/2015 Research Scientist, Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI
01/01/2016 - 06/30/2021 Assistant Investigator, Blood Research Institute, Versiti, Milwaukee, WI
07/01/2020 - Present Associate Professor, Internal Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
07/01/2021 - Present Associate Investigator, Blood Research Institute, Versiti, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
07/2010 - 09/2010 Chief Fellow, Department of Internal Medicine, Division of Hematology and Oncology, Weill Cornell Medical Center; New York Presbyterian Hospital, New York, NY
07/01/2020 - 06/30/2021 Associate Program Director (Research Focus), Hematology and Oncology Fellowship Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
02/2021 - Present Associate Program Director- Medicine Residency, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
07/2011 - 12/2012 New York Presbyterian- Weill Cornell, 520 East 70th, New York, NY 10021
03/2013 - Present Froedtert Hospital- Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee WI, 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Internal Medicine
08/2011
12/2021
ABIM - Hematology
10/2012
12/2022
 
Certificates
Issued By Issue DateExpiration
CPR
AHA
03/2010
03/2012
ACLS
AHA
03/2010
03/2012
 

Licensure
Number Issue DateExpiration
New York License
08/04/2008
03/31/2014
Wisconsin
02/25/2013
10/31/2021
 

AWARDS AND HONORS:
1998 - 2000 Molecular biosciences NIH trainee, University of Wisconsin- Madison
2001 Student travel award, Internal Workshop on Molecular and Celular Biology of Plasminogen Activation
07/2005 - 06/2006 F.M. Kirby Postdoctoral Fellowship in Sensory Neuroscience, The Rockefeller University
2005 - Present Postdoctoral travel award, --International Workshop on Molecular and Cellular Biology of Plasminogen Activation; Washington DC
05/2010 - Present Finalist Fellows Research Award, Weill Cornell Medical College Department of Medicine
2015 - Present 'Best Doctors in America' designation
11/2016 Faculty Development Award, Department of Internal Medicine, Medical College of Wisconsin
06/2017 Daniel McCarty Award for Research Excellence, Department of Internal Medicine, Medical College of Wisconsin
06/01/2019 - 07/31/2019 Faculty Development Award, MCW, Department of Internal Medicine
10/28/2019 - Present Top Patient Experience Award, FY19, Medical College of Wisconsin and the Froedtert Hospital

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2010 - Present American Society of Hematology
2011 - Present American Society of Biochemistry and Molecular Biology
2014 - Present American Society of Matrix Biology
2016 - Present International Society of Experimental Hematology

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
06/2017 - Present Hematology (ad hoc)
09/2018 - Present Journal of General Internal Medicine (ad hoc)
05/2019 - Present International Journal of Stem Cell Research and Therapy (ad hoc)
12/2019 - Present Journal of Thrombosis and Hemostasis (ad hoc)
06/2020 - Present PloS one (ad hoc)
06/2020 - Present Translational Oncology, International Advisory and Reviewer Board

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
08/2017 - Present Member, National Marrow Donor Program Institutional Review Board, National Marrow Donor Program
05/2018 - Present Reviewer, Leukemia Research Foundation

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Schwann Cells in Hematopoiesis (R03)
Source:
NHLBI
Role:
PI
Dates:
12/01/2020 - 11/30/2022
Direct Funds:
$100,000
 
Title:
MDS/AML in Myeloma
Source:
MCW Cancer Center
Role:
Co-PI
Dates:
03/01/2021 - 11/30/2022
Direct Funds:
$75,000 (Shared with Dr. Sridhar Rao (co-PI): Team Science Award, Project 4)
 
Non-Peer Review
Title:
Leukemia Research
Source:
Paulette Kroll Leukemia Research Fund, MCW Philanthropy
Role:
PI
Dates:
06/13/2019 - Present
Direct Funds:
$4,885
 
Title:
Neural Regulation of AML
Source:
Froedtert Hospital and the Scott Garrett Leukemia Research Foundation
Role:
PI
Dates:
- 2019
Direct Funds:
$88,000
 
Prior
Peer Review
Title:
Laminin Expression is Necessary for Endothelial Function and Hematopoiesis
Source:
CTSC
Role:
PI
Dates:
07/01/2011 - 05/31/2013
Direct Funds:
$90,000 (Rockefeller and Weill Cornell College of Medicine)
 
Title:
Bone Marrow Failure in Mice Deficient for the Extracellular Matrix Component, Laminin-gamma1
Source:
NIH Heart Lung and Blood Institute
Role:
PI
PI:
Karen-Sue Carlson
Dates:
04/01/2015 - 03/31/2020
Direct Funds:
$719,054 (K08 Career Development Award)
 
Title:
Acute Myelogenous Leukemia Interface with Hematopoietic Niche
Source:
MCW Cancer Center
Role:
PI
PI:
K Carlson
Dates:
12/01/2017 - 11/30/2018
Direct Funds:
$50,000
 
Non-Peer Review
Title:
Aplastic Anemia and the Bone Marrow Hematopoietic Niche
Source:
Froedtert Hospital Foundation; Aplastic Anemia Cancer Research Fund
Role:
PI
PI:
K Carlson
Dates:
10/01/2015 - 09/30/2016
Direct Funds:
$30,000
 
Title:
SEATTLEGEN-SGN123-001-AML
Source:
Seattle Genetics
Role:
Institutional PI
Direct Funds:
$0 (Trial closed prior to patient enrollment)
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
K. Carlson, Leukemia Highlights, LLS 6th Annual ASH Review Program, New York, NY, 02/2012 - Present
K. Carlson, Chronic Lymphocytic Leukemia, Leukemia Survivorship Conference, LLS, Oshkosh, WI, 02/21/2015 - Present
K. Carlson, New Tools, New Challenges: Treating Adult Acute Lymphocytic Leukemia (ALL) in 2015, 4th Annual Controversies in Hematologic Malignancies Symposium, Milwaukee, WI, 03/07/2015 - Present
K. Carlson, The Extracellular Matrix is an Active Contributor to Hematopoiesis, 2nd Annual Department of Medicine Research Retreat, Milwaukee, WI, 03/18/2016 - Present
K. Carlson, Molecular Diagnostics in Myeloid Malignancies, 6th Annual Controversies in Hematologic Malignances Symposium, Milwaukee, WI, 03/04/2017 - Present
K. Carlson, What Works for Women at Work (panelist), Council for Women's Advocacy Noon Series, Milwaukee, WI, 03/06/2018 - Present
K. Carlson and K. Wiger, Perspective taking in Oncology Education, Kern Kinetic3 Teaching Academy Graduation, Milwaukee, WI, 06/05/2019 - Present
K. Carlson, Mentorship in the Diversity for Summer Health Related Research Program (DSHREP), Mentor Appreciation Luncheon, Milwaukee, WI, 07/29/2019 - Present
K. Carlson, Research at the Blood Research Institute, VBRI Legacy Society Breakfast, WI, 05/20/2021 - Present
 
Regional
K. Carlson, Treating Acute Myelogenous Leukemia in 2019, Wisconsin Association of Blood Banks (WABB) Annual Meeting, Pewaukee, WI, 09/12/2019 - Present
Carlson K., Hematopoiesis, of all the Nerve!, Appetite for Research, Versiti-wide broadcast, 05/12/2020 - Present
 
National
K. Carlson, K08 Presentation, ASH Junior Researcher Symposium, Orlando, FL, 12/04/2015 - Present
K. Carlson, Hematopoietic Niche in Leukemia, 6th Annual Houston Methodist Cancer Symposium, Houston, TX, 10/17/2018 - Present
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Kermani P, Ramnarain A, Catena R, Chen ZL, Hempstead B, Strickland S, Carlson K. Laminin Expression is Necessary for Maintenance of the Vascular Hematopoietic Niche. ASH. San Diego CA, December 2011. (Oral presentation)
Barker-Carlson K, Strickland S. The Extracellular Matrix (ECM) is Critical for the Function of the Peripheral Nervous System. Adelson Program for Neural Regeneration and Rehabilitation, Las Vegas NV, December 2005. (Oral presentation)
Barker-Carlson K, Lawrence D, Schwartz B. Two-Chain and Single-Chain Tissue-Type Plasminogen Activator Deacylate Neuroserpin Acyl-enzyme Complexes at Different Rates. VIIIth International Workshop on Molecular and Cellular Biolo, Wyoming. September 2001. (Oral Presentation)
 
International
Barker-Carlson K, Lawrence D, Schwartz K, Schwartz B. pH as a modulator of t-PA-neuroserpin interactions. EMBO Conference-- Extracellular Proteases and Their Inhibitors in Development, Plasticity, and Pathology of the Nervous System. Ascona, Switzerland. March 2003. (Oral Presentation)
Barker-Carlson K, Olowe O, Lawrence D, Schwartz B. Characterization of the Interactions Between Tissue-Type Plasminogen Activator and Neuroserpin. Meeting of the International Society for Thrombosis and Hemostasis. Paris, France. June, 2001. (Poster)
 

COMMITTEE SERVICE:
Medical College of Wisconsin
05/2013 - 06/2014 Member, 4NT internal medicine house staff education committee, Hematology and Oncology, Internal Medicine, Medical College of Wisconsin
07/01/2017 - Present Member, Internal Medicine Residency Program Evaluation Committee, Hematology and Oncology, Internal Medicine, Medical College of Wisconsin
10/2017 - 12/2018 Member, Stem Cell Faculty recruitment search committee, Blood Research Institute, Versiti
05/2020 - 06/30/2021 Chair, BRI Return To Work Committee, Blood Research Institute, Versiti
05/2020 - 07/2020 Member, Versiti Laboratory Return to Work Sub-Group, Blood Research Institute, Versiti
05/2020 - 05/2021 Member, Versiti Return to Work Task Force, Blood Research Institute, Versiti
06/2020 - 06/2021 Member, Hematology and Oncology Clinical Competency Committee, Hematology and Oncology, Internal Medicine, Medical College of Wisconsin
06/2020 - 06/2021 Member, Hematology and Oncology Program Evaluation Committee, Hematology and Oncology, Internal Medicine, Medical College of Wisconsin
12/2020 - 06/2021 Clinical Chair, Transplant and Oncology Portfolio Management Team, Blood Research Institute, Versiti
02/2021 - Present Member, Internal Medicine Residency Clinical Competency Committee, Internal Medicine, Medical College of Wisconsin
05/2021 - Present Member, MSTP-Director Search Committe, Medical College of Wisconsin
 
Hospital
03/2015 - 10/2015 Physician Sponsor, Malignant Hematology Pod in Day Hospital Committee, Hematology and Oncology, Internal Medicine, Medical College of Wisconsin and Froedtert
08/2017 - 01/2018 Chair and member, Oncology/ICU collaborative care working group, Hematology and Oncology, Internal Medicine, Medical College of Wisconsin and Froedtert
12/2018 - 06/30/2021 Member, Precision Medicine Assay Evaluation Committee, Medical College of Wisconsin, Internal Medicine, Medical College of Wisconsin and Froedtert
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
07/2011 - 12/2012 Medical student teaching on inpatient leukemia service. Lecture during leukemia section of Basis of Disease Course. Weill Cornell College of Medicine.
 
Resident and Fellow Education
07/2012 - 12/2012 Resident and fellow teaching on inpatient leukemia service, Fellowship lectures on acute myeloid leukemia, teaching attending during fellows hematology clinic. Weill Cornell College of Medicine.
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
High School Students
Alexandra Rosenberg 09/2004 - 05/2006 Capacity (Advisor- Natural History Museum Student Research Program, and Advisor for Hunter College High School Externship)
 

ROBERT D. AND PATRICIA E. KERN INSTITUTE FOR THE TRANSFORMATION OF MEDICAL EDUCATION AND NATIONAL TRANSFORMATION NETWORK ACTIVITIES:
07/01/2018 - 05/31/2019 Participant in KINETIC3 Teaching Academy
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Khan M, Roddy JT, Hernandez JR, Bursch K, Bal N, Carlson KS, Bergl PA. Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH-inhibitor therapy for AML. Br J Haematol. 2021 Sep;194(6):1083-1085.
2. Wang W, Auer P, Zhang T, Spellman S, Carlson KS, Nazha A, Bolon YT, Saber W. Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndromes. Transplant Cell Ther. 2021 08;27(8):659.e1-659.e6. PMCID: PMC8421055
3. Dhakal B, Wang T, Kuxhausen M, Zhu F, Taylor C, Spellman SR, Verneris MR, Hsu K, Fleischhauer K, Lee SJ, Bolon YT, Carlson KS, Nazha A, Saber W. Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant. Leuk Lymphoma. 2021 01;62(1):229-233. PMCID: PMC7939047
4. Yang C, Siebert JR, Burns R, Zheng Y, Mei A, Bonacci B, Wang D, Urrutia RA, Riese MJ, Rao S, Carlson KS, Thakar MS, Malarkannan S. Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature. Elife. 2020 05 14;9. PMCID: PMC7255804
5. Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, Atallah E. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database. J Natl Compr Canc Netw. 2020 02;18(2):169-175.
6. Basu S, Liang HPH, Hernandez I, Zogg M, Fields B, May J, Ogoti Y, Wyseure T, Mosnier LO, Burns RT, Carlson K, Weiler H. Role of thrombomodulin expression on hematopoietic stem cells. J Thromb Haemost. 2020 01;18(1):123-135. PMCID: PMC6940513
7. Fields B, DeLaForest A, Zogg M, May J, Hagen C, Komnick K, Wieser J, Lundberg A, Weiler H, Battle MA, Carlson KS. The Adult Murine Intestine is Dependent on Constitutive Laminin-γ1 Synthesis. Sci Rep. 2019 12 17;9(1):19303. PMCID: PMC6917708
8. Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, Routes JM, Verbsky JW, Thakar MS, Malarkannan S. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat Commun. 2019 09 02;10(1):3931. PMCID: PMC6718415
9. Izaguirre-Carbonell J, Christiansen L, Burns R, Schmitz J, Li C, Mokry RL, Bluemn T, Zheng Y, Shen J, Carlson KS, Rao S, Wang D, Zhu N. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia. Blood Adv. 2019 05 14;3(9):1499-1511. PMCID: PMC6517669
10. Schneidewend R.a · Hosking P.b · Brazauskas R.c · Peterson J.b · Beaudin C.a · Michaelis L.a · Atallah E.a · Hari P.a · Carlson K. Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy Acta Haematologica. Acta Haematol 2018;139:171–175 .
11. Levin A, Kleman A, Rein L, Tarima S, Michaelis LC, Carlson KS, Hamadani M, Fenske TS, Hari P, Atallah E, Dhakal B. Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysis. Am J Hematol. 2017 Sep;92(9):E563-E565.
12. Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M. Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2017 Aug;23(8):1295-1302.
13. van Mens TE, Liang HH, Basu S, Hernandez I, Zogg M, May J, Zhan M, Yang Q, Foeckler J, Kalloway S, Sood R, Karlson CS, Weiler H. Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation. Blood Adv. 2017 Jun 27;1(15):1148-1158. PMCID: PMC5600150
14. Carlson KS, Nguyen L, Schwartz K, Lawrence DA, Schwartz BS. Neuroserpin Differentiates Between Forms of Tissue Type Plasminogen Activator via pH Dependent Deacylation. Front Cell Neurosci. 2016;10:154. PMCID: PMC4908126
15. Hanif A, Hari PN, Atallah E, Carlson KS, Pasquini MC, Michaelis LC. Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. Bone Marrow Transplant. 2016 Apr;51(4):617-8.
16. Chapin J, Carlson K, Christos PJ, DeSancho MT. Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions. Clin Appl Thromb Hemost. 2015 Oct;21(7):672-7.
17. Ebenezer GJ, Carlson K, Donovan D, Cobham M, Chuang E, Moore A, Cigler T, Ward M, Lane ME, Ramnarain A, Vahdat LT, Polydefkis M. Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients. Ann Clin Transl Neurol. 2014 Sep;1(9):639-49. PMCID: PMC4241791
18. Ritchie EK, Feldman EJ, Christos PJ, Rohan SD, Lagassa CB, Ippoliti C, Scandura JM, Carlson K, Roboz GJ. Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia. Leuk Lymphoma. 2013 Sep;54(9):2003-7. PMCID: PMC3888021
19. Carlson KB, Singh P, Feaster MM, Ramnarain A, Pavlides C, Chen ZL, Yu WM, Feltri ML, Strickland S. Mesenchymal stem cells facilitate axon sorting, myelination, and functional recovery in paralyzed mice deficient in Schwann cell-derived laminin. Glia. 2011 Feb;59(2):267-77. PMCID: PMC3118468
20. Mallik A, Carlson KB, DeSancho MT. A Patient with "Spontaneous" Heparin-induced Thrombocytopenia and Thrombosis after Undergoing Knee Replacement, Blood Coagulation and Fibrinolysis. Blood Coagulation and Fibrinolysis; 22(1):73-5. January 2011.
21. Mallik A, Carlson KB, DeSancho MT. A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement. Blood Coagul Fibrinolysis. 2011 Jan;22(1):73-5.
22. Barker-Carlson K, Lawrence DA, Schwartz BS. Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro. J Biol Chem. 2002 Dec 06;277(49):46852-7.
 
Books, Chapters, and Reviews
1. Carlson K, Morris J, Cross L, Rao S. Stem Cell Biology in Bone Marrow Transplantation. Contemporary Stem Cell Transplantation (Living Reference on SpringerLink). January 30, 2021.
2. Tang J, Zhu N, Rao S, Carlson KS. Stem cell damage after chemotherapy- can we do better? Best Pract Res Clin Haematol. 2019 03;32(1):31-39.
3. Principles of Critical Care, Fourth Edition. Chapter 92: Acute Leukemia. Publication date June 2, 2015. ISBN 0071738819 / 9780071738811
4. Atallah Ehab, Carlson Karen Sue, Schiffer Charles. Should all adults with acute lymphocytic leukemia receive allogeneic stem cell transplantation in first remission? International Journal of Hematologic Oncology. Atallah E, Carlson Karen Sue, Schiffer Charles. Should all adults with acute lymphocytic leukemia receive allogeneic stem cell transplantation in first remission? International J.
5. Carlson KS, Guzman ML. Is minimal residual disease monitoring clinically relevant in adults with acute myelogenous leukemia? Curr Hematol Malig Rep. 2013 Jun;8(2):109-15. PMCID: PMC3661756
6. Carlson K, Ocean AJ. Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach. Clin Breast Cancer. 2011 Apr;11(2):73-81.
7. Carlson KS, DeSancho MT. Hematological issues in critically ill patients with cancer. Crit Care Clin. 2010; 107-32.
8. Barker-Carlson K. Characterization of the interactions between neuroserpin and tissue-type plasminogen activator. Ph.D. Dissertation. University of Wisconsin-Madison. September 2002.
9. Carlson KS, DeSancho MT. Hematological issues in critically ill patients with cancer. Crit Care Clin. 2010 Jan;26(1):107-32.
10. Karen Carlson; Jesse B. Hall, Gregory A. Schmidt, John P. Kress Editors.. Acute Leukemia Principles of Critical Care, Fourth Edition. .
 
Abstracts
1. Carlson KB, Rabbany P, Ramnarain A, Strickland S. Disruption of Laminin- 1 Expression Induces Rapid Decrease in Spleen Size. ASH 2010. Orlando FL, December 2010. (Poster).
2. Carlson KB, Ramnarain A, Strickland S, Vahdat L. Development of ixabepilone-induced CIPN is related to pre-treatment with paclitaxel in a mouse model. AACR. Washington D.C, April 2010. (Poster).
3. DeSancho MT, Carlson K, Mallik A. A Case of Spontaneous Heparin Induced Thrombocytopenia and Thrombosis. ISTH. Boston MA, July 2009. (Poster).
4. DeSancho MT, Powell-Boone K, Carlson K. Prevalence of Thrombophilia in Patients with Retinal Vascular Occlusion. ASH. San Francisco CA, December 2008. (Publication only)
5. Barker-Carlson K, Rosenberg A, Chen ZL, Yu WM, Strickland S. The Role of Laminin, a Plasmin Substrate, in Maintenance of the Peripheral Nerve. IX International Workshop on Molecular and Cellular Biology of Plasminogen Activation. Washington D.C., April 2005. (revised title; Poster)
6. Barker-Carlson K, Lawrence D, Schwartz B. Biochemical characterizations of the interactions between tissue-type plasminogen activator and neuroserpin leads to the development of a model for t-PA inhibition by neuroserpin. 2002 MD/PhD Student Conference. Aspen/Snowmass, Colorado. July 2002. (Poster)
7. Barker-Carlson K, Guerra R, Lawrence D, and Schwartz, B. Regulation of T-PA: Neuroserpin Complex Deacylation by pH. 3rd International Serpin Symposium. Chicago, Illinois. June 2002. (Poster)
8. Swartling, D., K. Barker, S. Jeffrey, & E. Biehl, Synthesis of 8-substituted adenosines and deoxyadenosines for use as fluorescent tags and molecular probes (Medicinal Chemistry Section) National Meeting American Chemical Society held in San Diego, March 13-17, 1994. (Poster)
9. Swartling, D., K. Barker, S. Jeffrey, M. Fry, M. Morgan, & E. Biehl, Synthesis of anthracene-substituted thymidines, adenosines, and deoxyadenosines for use as fluorescent tags and molecular probes (Chemistry Education Section) National Meeting American Chemical Society held in San Diego, March 13-17, 1994. (Poster)
10. 11. Basu S, Hernandez I, Zogg M, Weiler H, Carlson K-S, Kermani P. Physiologic Hematopoiesis is Dependent on Stromal Expression of Laminin-γ1. ASH National Meeting, Orlando FL. December 4-8, 2015.
11. Fields B, May J, Zogg M, DeLaForest A, Battle M, Weiler H, Carlson K. β1-Integrin Glycosylation is Modified in Laminin-ɣ1 Deficient Murine Small Intestine. 2018 Great Lakes Glycomics Symposium. Milwaukee WI. May 31, 2018.
12. Carlson K, Basu S, Kermani P, Hernandez I, Zogg M, May K, Fields B, Weiler H, Nascent laminin-ɣ1 synthesis regulates the steady-state adult bone marrow hematopoietic niche. American Society for Matrix Biology Biennial Meeting, Las Vegas NV. October 13-17, 2018.
13. Carlson K, Fields B, May J, Hernandez I, Zogg M, DeLaForest A, Weiler H, Battle M. Laminin-γ1 Is Necessary for Adult Murine Intestinal Epithelial- Mesenchymal Homeostasis. American Society for Matrix Biology Biennial Meeting, Las Vegas NV. October 13-17, 2018. (Poster)
14. Fields B, Kermani P, Hernandez I, Basu S, Wieser J, May J, Weiler H, Carlson K. Laminin-gamma1 Maintains Hematopoietic Nerve-Microvascular Units. 2019 Great Lakes Glycomics Symposium. Milwaukee WI. May 31, 2019.
15. Kristin Komnick, Jennifer May, Pouneh Kermani, Sreemanti Basu, Irene Hernandez, Mark Zogg, British L Fields, Joshua Morris, Hartmut Weiler, and Karen-Sue Carlson. Dependence on Schwann Cell-Derived Laminin-γ1 Differentiates Early Lymphoid and Myeloid Development. American Society of Hematology National meeting, December 2020 (Virtual)